Court Affirms Mylan Does Not Infringe, Will Not Reverse Ruling on Prilosec Patents
BNA's Pharmaceutical Law & Industry Reporter (06/13/2008)
Colin Underwood discusses the U.S. Court of Appeals for the Federal Circuit's decision not to reverse a lower court's ruling that Mylan's Prilosec product did not infringe two AstraZeneca patents.
Related Individuals:COLIN A. UNDERWOOD Related Practice Areas:Patent Law
Related Individuals: